| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H30ClN3O4 |
| Molecular Weight | 411.923 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCOC1=CC(N)=C(Cl)C=C1C(=O)NC2CCN(CC3OCCO3)CC2
InChI
InChIKey=BTBFXLRQGPHRGT-UHFFFAOYSA-N
InChI=1S/C20H30ClN3O4/c1-2-3-8-26-18-12-17(22)16(21)11-15(18)20(25)23-14-4-6-24(7-5-14)13-19-27-9-10-28-19/h11-12,14,19H,2-10,13,22H2,1H3,(H,23,25)
| Molecular Formula | C20H30ClN3O4 |
| Molecular Weight | 411.923 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Dobupride is a substituted benzamide drug, which has shown powerful gastroprokinetic activity in animal studies, inducing gastric emptying and intestinal motility and increasing the resting pressure of the lower oesophageal sphincter. Compared with metoclopramide, both drugs increased stomach emptying of liquid and also increased the lower oesophageal sphincter pressure, but after metoclopramide administration more adverse effects (such as anxiety, drowsiness, and sweating) were reported.
